Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antiviral drug
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:drugClass |
direct-acting antiviral
|
| gptkbp:example |
gptkb:beclabuvir
gptkb:dasabuvir gptkb:sofosbuvir |
| https://www.w3.org/2000/01/rdf-schema#label |
NS5B polymerase inhibitor
|
| gptkbp:mechanismOfAction |
inhibits viral RNA replication
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:target |
NS5B RNA-dependent RNA polymerase
|
| gptkbp:usedFor |
treatment of hepatitis C
|
| gptkbp:bfsParent |
gptkb:Sofosbuvir
gptkb:Sovaldi gptkb:sofosbuvir gptkb:GS-7977 |
| gptkbp:bfsLayer |
6
|